Symbols

LFWD

Lifeward·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 1

Consensus Rating "Strong Buy"

EPS Beats Expectation

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About LFWD

Lifeward Ltd.

A supplier of exoskeleton medical equipment

Industry

Healthcare Equipment and Supplies

Established Date

06/20/2001

Listing Date

09/12/2014

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.golifeward.com

Security Type

Common stock

Office address

2 Cabot Rd., Hudson, MA 01749

Business

Introduction

Lifeward Ltd., was established in Israel on June 20, 2001. The company is an innovative medical device company that is designing, developing and commercializing exoskeletons that enable wheelchair users with mobility impairments or other medical conditions to stand and walk again. The company has developed and is continuing to commercialize ReWalk, an exoskeleton that uses the company's patented tilt sensor technology, as well as an onboard computer and motion sensors to drive electric legs that power motion.

Company Financials

EPS

LFWD has released its 2025 Q4 earnings. EPS was reported at -2.85, versus the expected -0.08, missing expectations. The chart below visualizes how LFWD has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

LFWD has released its 2025 Q4 earnings report, with revenue of 5.08M, reflecting a YoY change of -32.66%, and net profit of -5.35M, showing a YoY change of 65.00%. The Sankey diagram below clearly presents LFWD's revenue sources and cost distribution.